- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA to hold medical software hearing
The Food and Drug Administration and the National Library of Medicinehave scheduled a workshop in September to discuss the FDA's regulationof medical software. The meeting is intended to clarify confusionregarding requirements that apply to medical
The Food and Drug Administration and the National Library of Medicinehave scheduled a workshop in September to discuss the FDA's regulationof medical software. The meeting is intended to clarify confusionregarding requirements that apply to medical software devicesand accessories, according to the agency.
The workshop is scheduled for Sept. 3 and 4 at the NationalInstitutes of Health, Natcher Conference Center, 45 Center Dr.,Bethesda, MD. For more information contact Charles Furfine ofthe FDA's Center for Devices and Radiological Health at 301/443-2536,ext. 16. Information related to the workshop can also be accessedon the FDA's World Wide Web home page at http://www.fda.gov.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
